ID   ISH4
AC   CVCL_E711
AS   CVCL_F551
SY   ENDO; Extract 281; Extract 488
DR   dbMHC; 48908
DR   IHW; IHW09371
DR   IPD-IMGT/HLA; 10565
DR   Wikidata; Q54898279
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/350cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:18,11:01; B*15:01,46:01; C*01:02,04:01:01; DPB1*02:02,05:01; DQB1*03:02:01,06:01:01; DRB1*04:06,08:03:02; DRB4*01:03:01:01 (IPD-IMGT/HLA=10565).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//